HLA-DMA alleles are possible new markers of rheumatoid arthritis: study of a Corsican group

Exp Clin Immunogenet. 1999;16(4):192-8. doi: 10.1159/000019111.

Abstract

The HLA-DMA gene, along with the HLA-DMB gene, encodes the not classical class II molecule. This molecule catalyzes the class-II-associated invariant-chain peptide (CLIP)-antigen peptide exchange in classical class II molecule peptide-binding groove. As such, the DM heterodimer is an antigen presentation regulator and may be linked to immune system deficiencies such as those observed in autoimmune diseases. The study of DMA gene polymorphism seems be a reasonable approach to provide an answer to this question. Thanks to PCR-derived methods, the relationship between DMA gene polymorphism and rheumatoid arthritis (RA) was demonstrated in the present study. The DMA*0101 allele was observed to confer a significant predisposition to RA while the DMA*0102 allele significantly protected from this disease. Polymorphism experiments with the HLA-DRB1 gene revealed that this relationship between DMA polymorphism and RA is not a consequence of a linkage disequilibrium with the HLA-DRB1 alleles implicated in this pathology. The study of the DMA gene could therefore prove to be very useful in the early diagnosis of RA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Arthritis, Rheumatoid / genetics*
  • Arthritis, Rheumatoid / immunology
  • Biomarkers
  • DNA / genetics
  • France
  • Genetic Markers
  • Genotype
  • HLA-D Antigens / genetics*
  • HLA-D Antigens / immunology
  • Histocompatibility Antigens Class II*
  • Humans
  • Polymerase Chain Reaction
  • Polymorphism, Genetic

Substances

  • Biomarkers
  • Genetic Markers
  • H2-M antigens
  • HLA-D Antigens
  • HLA-DM antigens
  • Histocompatibility Antigens Class II
  • DNA